Charles Schwab’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $94.4K | Hold |
71,506
| – | – | ﹤0.01% | 3410 |
|
|
2026
Q1 | $98K | Hold |
71,506
| – | – | ﹤0.01% | 3387 |
|
|
2025
Q4 | $93.7K | Hold |
71,506
| – | – | ﹤0.01% | 3401 |
|
|
2025
Q3 | $90.1K | Hold |
71,506
| – | – | ﹤0.01% | 3396 |
|
|
2025
Q2 | $93.7K | Hold |
71,506
| – | – | ﹤0.01% | 3418 |
|
|
2025
Q1 | $104K | Hold |
71,506
| – | – | ﹤0.01% | 3335 |
|
|
2024
Q4 | $150K | Hold |
71,506
| – | – | ﹤0.01% | 3358 |
|
|
2024
Q3 | $150K | Sell |
71,506
-63,287
| -47% | -$93.6K | ﹤0.01% | 3358 |
|
|
2024
Q2 | $194K | Buy |
+134,793
| New | +$189K | ﹤0.01% | 3442 |
|
|
2024
Q1 | – | Sell |
-17,843
| Closed | -$26.8K | – | 3501 |
|
|
2023
Q4 | $26.8K | Hold |
17,843
| – | – | ﹤0.01% | 3461 |
|
|
2023
Q3 | $37.3K | Hold |
17,843
| – | – | ﹤0.01% | 3433 |
|
|
2023
Q2 | $41K | Hold |
17,843
| – | – | ﹤0.01% | 3443 |
|
|
2023
Q1 | $38.5K | Hold |
17,843
| – | – | ﹤0.01% | 3389 |
|
|
2022
Q4 | $36.6K | Hold |
17,843
| – | – | ﹤0.01% | 3421 |
|
|
2022
Q3 | $39K | Hold |
17,843
| – | – | ﹤0.01% | 3391 |
|
|
2022
Q2 | $46K | Hold |
17,843
| – | – | ﹤0.01% | 3404 |
|
|
2022
Q1 | $48K | Hold |
17,843
| – | – | ﹤0.01% | 3533 |
|
|
2021
Q4 | $48K | Hold |
17,843
| – | – | ﹤0.01% | 3518 |
|
|
2021
Q3 | $68K | Hold |
17,843
| – | – | ﹤0.01% | 3416 |
|
|
2021
Q2 | $76K | Sell |
17,843
-93,762
| -84% | -$404K | ﹤0.01% | 3315 |
|
|
2021
Q1 | $564K | Buy |
111,605
+11,955
| +12% | +$69.5K | ﹤0.01% | 3033 |
|
|
2020
Q4 | $525K | Buy |
99,650
+306
| +0.3% | +$1.75K | ﹤0.01% | 2976 |
|
|
2020
Q3 | $521K | Sell |
99,344
-3,396
| -3% | -$19.6K | ﹤0.01% | 2868 |
|
|
2020
Q2 | $557K | Buy |
102,740
+3,306
| +3% | +$17.5K | ﹤0.01% | 2787 |
|
|
2020
Q1 | $370K | Hold |
99,434
| – | – | ﹤0.01% | 2811 |
|
|
2019
Q4 | $671K | Buy |
99,434
+3,327
| +3% | +$25K | ﹤0.01% | 2720 |
|
|
2019
Q3 | $765K | Hold |
96,107
| – | – | ﹤0.01% | 2646 |
|
|
2019
Q2 | $926K | Buy |
96,107
+5,870
| +7% | +$61.9K | ﹤0.01% | 2599 |
|
|
2019
Q1 | $748K | Buy |
90,237
+4,002
| +5% | +$34.9K | ﹤0.01% | 2637 |
|
|
2018
Q4 | $705K | Hold |
86,235
| – | – | ﹤0.01% | 2648 |
|
|
2018
Q3 | $1.08M | Buy |
86,235
+7,000
| +9% | +$70.3K | ﹤0.01% | 2603 |
|
|
2018
Q2 | $631K | Buy |
79,235
+10,435
| +15% | +$108K | ﹤0.01% | 2724 |
|
|
2018
Q1 | $704K | Buy |
68,800
+11,600
| +20% | +$116K | ﹤0.01% | 2631 |
|
|
2017
Q4 | $371K | Buy |
57,200
+10,800
| +23% | +$71.6K | ﹤0.01% | 2808 |
|
|
2017
Q3 | $296K | Hold |
46,400
| – | – | ﹤0.01% | 2877 |
|
|
2017
Q2 | $245K | Hold |
46,400
| – | – | ﹤0.01% | 2952 |
|
|
2017
Q1 | $278K | Hold |
46,400
| – | – | ﹤0.01% | 2843 |
|
|
2016
Q4 | $280K | Hold |
46,400
| – | – | ﹤0.01% | 2868 |
|
|
2016
Q3 | $348K | Hold |
46,400
| – | – | ﹤0.01% | 2739 |
|
|
2016
Q2 | $351K | Buy |
+46,400
| New | +$336K | ﹤0.01% | 2726 |
|
Other funds holding MNOV
EWM
Charles Schwab's MNOV Position: Q2 2026 in Review
Charles Schwab held its MediciNova (MNOV) position steady in Q2 2026 at 71,506 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3410.
Charles Schwab first reported a position in MNOV in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.08M in Q3 2018. 29 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.
- Charles Schwab held 71,506 shares of MediciNova worth $94.4K as of Q2 2026.
- Charles Schwab left its MediciNova share count unchanged in Q2 2026.
- MediciNova made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3410 holding.
- Charles Schwab first reported a position in MediciNova in Q2 2016 and has held it in 40 quarters since.
- Charles Schwab's MediciNova position peaked at $1.08M in Q3 2018.
- 29 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.